---
title: No Treatment Effectiveness Rankings
description: >-
  Shockingly, the existing system does not give us a ranked list of the most safe and effective treatments for a given condition.
emoji: ðŸ“Š
---

# ðŸ“Š No Treatment Effectiveness Rankings

Placebo-controlled randomized controlled trials (RCTs) have long been the gold standard for evaluating new treatments. However, this approach has significant limitations when it comes to determining how treatments compare to each other in real-world settings.

## Problems with Placebo-Controlled Trials
1. **Decreased Ability to Determine Comparative Efficacy**  
   While placebo-controlled trials help establish a drug's efficacy compared to no treatment, they make it difficult to determine how it compares to existing therapies. This leaves clinicians and patients without clear guidance on which treatment might work best for their specific situation.

2. **Limited Generalizability**  
   RCTs often use strict inclusion criteria that may exclude important patient populations, making results less applicable to real-world practice [source](https://pmc.ncbi.nlm.nih.gov/articles/PMC6223979/).

3. **High Costs and Time Constraints**  
   The rigorous requirements of placebo-controlled trials make them expensive and time-consuming, potentially delaying access to effective treatments.

## Benefits of Comparative Effectiveness Trials
1. **Real-World Relevance**  
   Comparative effectiveness trials provide direct comparisons between treatments, offering more practical information for clinical decision-making [source](https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1038-2).

2. **Broader Patient Populations**  
   These trials often include more diverse patient groups, better reflecting the populations that will actually use the treatments.

3. **Cost-Effectiveness Data**  
   Comparative trials can provide valuable information about the cost-effectiveness of different treatment options.

## The Role of Real-World Data
1. **Complementing Traditional Trials**  
   Real-world evidence from observational studies can supplement RCT data, particularly for understanding long-term outcomes and rare side effects [source](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033114/).

2. **Pragmatic Trial Designs**  
   Pragmatic trials that incorporate real-world data help bridge the gap between research and clinical practice [source](https://www.nejm.org/doi/full/10.1056/NEJMra1510059).

3. **Regulatory Acceptance**  
   The FDA is increasingly recognizing the value of real-world evidence in regulatory decision-making [source](https://www.fda.gov/media/120060/download).

## Conclusion
While placebo-controlled trials remain important for establishing initial efficacy, the future of medical research lies in combining their strengths with comparative effectiveness research and real-world data. This approach will provide more comprehensive, practical information to guide treatment decisions and improve patient outcomes.
